Barely Significant
← all excerpts

Adjuvant Imatinib Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor: A Retrospective Analysis.

Cancer Res Treat · 2022 · PMC9582464 · PMID 34883555

Europe PMCDOI
1
hedged sentence
0.0890
closest p · 1.8× alpha
0.0890
boldest claim

The sentences

showed a trendp=0.089so close (0.05 < p ≤ 0.1)
Among patients who had a KIT exon 11 mutation (n=40), the 5-year group still showed a trend toward a better RFS (p=0.089; 4-year RFS, 83.3% vs. 61.5%, respectively) ( S3 Fig. ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.